In my mind the new scenario re AZ could be either a good thing or a bad thing. If IDT was going to be fill and finishing CSL’s overflowing AZ production, it’s not good, but if IDT was going to develop the capacity to produce another vaccine, then it’s good.
Anyone have any idea which it might be?
Ann: COVID19 Vaccine Feasibility Assessment, page-475
-
- There are more pages in this discussion • 456 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IDT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.005(4.00%) |
Mkt cap ! $55.87M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.0¢ | 12.5¢ | $15.96K | 123.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 451665 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 538641 | 8 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| IDT (ASX) Chart |